Byotrol PLC EPA Approval and Target Roll-Out (3379R)
28 February 2019 - 6:00PM
UK Regulatory
TIDMBYOT
RNS Number : 3379R
Byotrol PLC
28 February 2019
28(TH) February, 2019
Byotrol Plc
("Byotrol" or the "Company")
APPROVAL FOR NEW LONG-LASTING ANTI-MICROBIAL PRODUCT
VARIANTS
FROM EPA AND ALL US STATES
RETAIL TRIAL WITH TARGET TO BE EXTENDED TO MORE STORES FROM
APRIL, 2019
Byotrol plc, the specialist anti-microbial technology company,
is pleased to announce that it has completed the product
registration process in the US for two new, improved versions of
its 24-hour germ-kill surface sanitizer, 'Byotrol24'.
The new variants include proprietary, newly-developed
long-lasting fragrances to give a strong sensory cue to consumers
that the product continues to work for 24 hours.
With the approvals in place, Byotrol is now able to supply the
new variants to its US retail partner Target, which will be putting
them on shelf in 207 stores - increased from 156 - from April,
2019.
Additional fragrance versions of Byotrol24 are currently under
development and are likely to lead to a further-broadened product
range, including a re-positioned un-fragranced version, from
October 2019
David Traynor, Chief Executive of Byotrol plc comments:
"We have learnt a lot about US consumer requirements for
products of this type and are now tailoring Byotrol24 based on
those learnings. This includes working closely with specialist US
fragrance houses that are highly-attuned to US consumer tastes.
We are very encouraged that Target is now putting us into many
more of its stores and we are now also talking to other potential
US retailers. The US opportunity remains substantial and we
continue to make very good progress, but we will remain cautious on
spending until we have material revenue traction."
Enquiries:
01925 742 000
David Traynor - Chief Executive, Byotrol plc
finnCap Ltd
020 7220 0500
(Nominated Adviser & Broker)
Geoff Nash/ Kate Bannatyne - Corporate Finance
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist
anti-microbial technology company, operating globally in the Food,
Industrial, Healthcare and Consumer sectors, providing low toxicity
products with a broad-based and targeted efficacy across all
microbial classes; bacteria, viruses, fungi, moulds, mycobacteria
and algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where Byotrol can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, please go to www.byotrol.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCSEFFWWFUSESE
(END) Dow Jones Newswires
February 28, 2019 02:00 ET (07:00 GMT)
Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2024 to Jun 2024
Byotrol (LSE:BYOT)
Historical Stock Chart
From Jun 2023 to Jun 2024